- Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders
- Postpartum hormonal contraceptive use in Denmark during 1997-2021
- Measuring psychological well-being in a danish pregnancy cohort using the self-reported WHO-5 index
- Disturbing sleep in female adolescent mice does not increase vulnerability to depression triggers later in life
- Women’s perceptions of biological causes and potentials of genomic risk markers in postpartum depression: A qualitative study
- Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Growth Differentiation Factor 15 during pregnancy and postpartum as captured in blood, cerebrospinal fluid and placenta: A cohort study on associations with maternal mental health
- DNA methylation of serotonin genes as predictive biomarkers of antidepressant treatment response
- Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Association Between Intrauterine System Hormone Dosage and Depression Risk
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- Rumination in patients with major depressive disorder before and after antidepressant treatment
- No association between peripheral serotonin-gene-related DNA methylation and brain serotonin neurotransmission in the healthy and depressed state
- The cortisol awakening response is blunted in healthy women early postpartum
- Serotonin 4 receptor brain binding and oxytocin-promoted affective and social cognition in healthy women – A randomized controlled trial
- EEG abnormalities are not associated with poor antidepressant treatment outcome – A NeuroPharm study
- Postpartum and non-postpartum depression: a population-based matched case-control study comparing polygenic risk scores for severe mental disorders
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Genetic contributions to brain serotonin transporter levels in healthy adults
- Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal
- Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
- Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study
- The association between brain serotonin transporter binding and impulsivity and aggression in healthy individuals
- Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression-a NeuroPharm study
- Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
- Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression
- Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
- Deep phenotyping towards precision psychiatry of first-episode depression – the Brain Drugs-Depression cohort
- Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression
- Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder
- Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction
- AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
- Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
- Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
- Reliability of three versus five saliva sampling times for assessing the cortisol awakening response
- Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
- Postpartum depression: a developed and validated model predicting individual risk in new mothers
- Family History of Psychiatric Disorders as a Risk Factor for Maternal Postpartum Depression: A Systematic Review and Meta-analysis
- Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women
- Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
- Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study
- Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
- The role of central serotonergic markers and estradiol changes in perinatal mental health
- Evaluation of the Effect of Supervised Group Exercise on Self-Reported Sleep Quality in Pregnant Women with or at High Risk of Depression: A Secondary Analysis of a Randomized Controlled Trial
- Brain serotonin transporter is associated with cognitive-affective biases in healthy individuals
- Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
- Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study
- Family history of psychiatric disorders as a risk factor for maternal postpartum depression: a systematic review protocol
- The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
- Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
- NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
- Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator
- Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
- Default mode network functional connectivity negatively associated with trait openness to experience
- Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape
- Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
- Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study
- Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
- Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression
- Effect of supervised group exercise on psychological well-being among pregnant women with or at high risk of depression (the EWE Study): A randomized controlled trial
- Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
- Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
- Pharmacological sex hormone manipulation as a risk model for depression
- Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
- Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms
- Perinatal Depression: Embracing Variability toward Better Treatment and Outcomes
- Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
- Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
- Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study
- Three weeks of SSRI administration enhances the visual perceptual threshold – a randomized placebo-controlled study
- Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study
- Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women
- Delirium assessment in neuro-critically ill patients: A validation study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Paroxetine blunts the corticosterone response to swim-induced stress and increases depressive-like behavior in a rat model of postpartum depression
- Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
- No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
- Testosterone levels in healthy men correlate negatively with serotonin 4 receptor binding
- Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
- Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial
- Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
- Seasonal difference in brain serotonin transporter binding predicts symptom severity in patients with seasonal affective disorder
- Sex hormone manipulation slows reaction time and increases labile mood in healthy women
- Brain serotonin 4 receptor binding is associated with the cortisol awakening response